Skip to main content
TipRanks
Go Ultimate75% OFF

InDex Pharmaceuticals Holding AB (1NP1) Cash flow

5 Followers

InDex Pharmaceuticals Holding AB Cash Flow

DE:1NP1's free cash flow for Q3 2026 was kr500.00K. For the 2026 fiscal year, DE:1NP1's free cash flow was increased by kr0.00 and operating cash flow was kr500.00K. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
kr -28.10Mkr -17.00Mkr -37.98Mkr -129.44Mkr -124.06M
kr -109.50Mkr -19.80Mkr -625.20Mkr 0.00kr 0.00
kr -195.50Mkr 571.90Mkr 634.70Mkr -818.00Kkr 486.39M
kr 540.20Mkr 865.10Mkr 294.27Mkr 344.93Mkr 428.45M
kr -28.10Mkr -17.00Mkr -37.98Mkr -129.44Mkr -124.06M

Currency in SEK

InDex Pharmaceuticals Holding AB Cash Flow

-750M-500M-250M0250M500M750M201720182019202020212022202320242025OperatingInvestingFinancing